Third dose of Covaxin gets approval for clinical trials,

The SEC has recommended that the trials of the booster shot be done during the second phase of clinical trials. The dose should be given six months …, The SEC has recommended that the trials of the booster shot be done during the second phase of clinical trials. The dose should be given six months …, Read More

Scroll to Top